A PCR approach to determine the distribution of toxin genes in closely related Clostridium species: Clostridium botulinum type C and D neurotoxins and C2 toxin, and Clostridium novyi α toxin

Journal of Medical Microbiology

Volumn 56, Issue PART 2, 2007, Pages 196-201

  Heffron, Ann ^a   Poxton, Ian R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOXIN; BOTULINUM TOXIN; BOTULINUM TOXIN C; BOTULINUM TOXIN C 2; BOTULINUM TOXIN D; CLOSTRIDIUM TOXIN; NEUROTOXIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIAL GENE; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; C2 GENE; CHEMICAL ANALYSIS; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM TYPE C; CLOSTRIDIUM BOTULINUM TYPE D; CLOSTRIDIUM NOVYI; CONTROLLED STUDY; DRUG USE; DYSAUTONOMIA; GENE IDENTIFICATION; GENETIC ANALYSIS; INJECTION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TOXIN GENE;

ANIMALS; BACTERIAL TOXINS; BOTULINUM TOXINS; CLOSTRIDIUM; CLOSTRIDIUM BOTULINUM; CLOSTRIDIUM INFECTIONS; ELECTROPHORESIS, AGAR GEL; GENES, BACTERIAL; HUMANS; NEUROTOXINS; POLYMERASE CHAIN REACTION; PROTEIN SUBUNITS;

EID: 33847225957     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46802-0     Document Type: Article

References (22)

1. Brown, R., Collee, J. G. & Poxton, I. R. (1996). Bacteroides, Fusobacterium and other Gram-negative anaerobic rods; anaerobic cocci; identification of anaerobes. In Mackie and McCartney's Practical Medical Microbiology. Edited by J. G. Collee, A. G. Fraser, B. P. Marmion & A. Simmonds. Edinburgh: Churchill Livingstone.
2. Collee, J. G., Brown, R. & Poxton, I. R. (1996). Clostridia of wound infection. In Mackie and McCartney's Practical Medical Microbiology. Edited by J. G. Collee, A. G. Fraser, B. P. Marmion & A. Simmonds. Edinburgh: Churchill Livingstone.
3. de Lamballerie, X., Zandotti, C., Vignoli, C., Bollet, C. & de Micco, P. (1992). A one-step microbial DNA extraction method using Chelex-100 suitable for gene amplification. Res Microbiol 143, 785-790.
4. Eklund, M. W., Poysky, F. T., Meyers, J. A. & Pelroy, G. A. (1974). Interspecies conversion of Clostridium botulinum type-C to Clostridium novyi type-A by bacteriophage. Science 186, 456-458.
5. Fujii, N., Kubota, T., Shirakawa, S., Kimura, K., Ohishi, I., Moriishi, K., Isogai, E. & Isogai, H. (1996). Characterization of component-I gene of botulinum C2 toxin and PCR detection of its gene in clostridial species. Biochem Biophys Res Commun 220, 353-359.
6. Hatheway, C. L. (1995). Botulism: the present status of the disease. Curr Top Microbiol Immunol 195, 55-75.
7. Hofmann, F., Herrmann, A., Habermann, E., and Von Eichel Streiber, C. (1995). Sequencing and analysis of the gene encoding the z-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile. Mol Gen Genet 247, 670-679.
8. Hunter, L. C. & Poxton, I. R. (2002). Clostridium botulinum types C and D and the closely related Clostridium novyi. Rev Med Microbiol 13, 75-90.
9. Hunter, L. C., Miller, J. K. & Poxton, I. R. (1999). The association of Clostridium botulinum type C with equine grass sickness: a toxicoinfection? Equine Vet J 31, 492-499.
10. Jones, J. A., Salmon, J. E., Djuretic, T., Nichols, G., George, R. C. & Gill, O. N. (2002). An outbreak of serious illness and death among injecting drug users in England during 2000. J Med Microbiol 51, 978-984.
11. Kimura, K., Kubota, T., Ohishi, I., Isogai, E., Isogai, H. & Fujii, N. (1998). The gene for component-II of botulinum C2 toxin. Vet Microbiol 62, 27-34.
12. McCarthy, H. E., French, N. P., Edwards, G. B., Poxton, I. R., Kelly, D. F., Payne-Johnson, C. E., Miller, K. & Proudman, C. J. (2004). Equine grass sickness is associated with low antibody levels to Clostridium botulinum: a matched case-control study. Equine Vet J 136, 123-9.
13. McGuigan, C. C., Penrice, G. M., Gruer, L., Ahmed, S., Goldberg, D., Black, M., Salmon, J. E. & Hood, J. (2002). Lethal outbreak of infection with Clostridium novyi type A and other spore-forming organisms in Scottish injecting drug users. J Med Microbiol 51, 971-977.
14. Nakamura, S., Serikawa, T., Yamakawa, K., Nishida, S., Kozaki, S. & Sakaguchi, G. (1978). Sporulation and C2 toxin production by Clostridium botulinum type-C strains producing no Cl toxin. Microbiol Immunol 22, 591-596.
15. Nunn, F., Cave, T. A., Knottenbelt, C. & Poxton, I. R. (2004). Evidence that Key-Gaskell Syndrome is a toxico-infection caused by Clostridium botulinum type C/D. Vet Rec 155, 111-115.
16. Ohishi, I., Iwasaki, M. & Sakaguchi, G. (1980). Purification and characterization of two components of botulinum C2 toxin. Infect Immun 30, 668-673.
17. Poxton, I. R. (2005). Other Clostridium species. In Principles mid Practice of Clinical Bacteriology, 2nd edn. Edited by S. H. Gillespie & P. M. Hawkey. Chichester: Wiley.
18. Poxton, I. R. & Byrne, M. D. (1984). Demonstration of shared antigens in the genus Clostridium by an enzyme-linked immunosorbent assay. J Med Microbiol 17, 171-176.
19. Sunagawa, H. & Inoue, K. (1991). Isolation and characterization of converting and non-converting phages, harbored in the strains of Clostridium botulinum type C and type-D isolated in Japan. J Vet Med Sci 53, 951-954.
20. Sunagawa, H. & Inoue, K. (1992). Biological and biophysical characteristics of phages isolated from Clostridium botulinum type-C and type-D strains, and physicochemical properties of the phage DNAs. J Vet Med Sci 54, 675-684.
21. Sunagawa, H., Ohyama, T., Watanabe, T. & Inoue, K. (1992). The complete amino-acid-sequence of the Clostridium botulinum type-D neurotoxin, deduced by nucleotide-sequence analysis of the encoding phage D-16-phi genome. J Vet Med Sci 54, 905-913.
22. Williamson, J. L., Rocke, T. E. & Aiken, J. M. (1999). In situ detection of the Clostridium botulinum type C-I toxin gene in wetland sediments with a nested PCR assay. Appl Environ Microbiol 65, 3240-3243.